ESR1 and breast carcinoma: Our group also showed that BOLCs (RUNX2- RANKL double positive breast cancer cells) significantly increase in estrogen receptor (ER) positive breast cancers rather than human epidermal growth factor receptor-2 (HER2) positive ones.